C4 Therapeutics OverviewC4 Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CCCC.
Quarterly EBIT
-$27.79M
↑ 4.73% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$111.06M
↑ 1.97% YoY
Trailing 12 months ending Mar 31, 2026
C4 Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for CCCC.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026